A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UNIFI)

Trial Details

  • 951 patients will be taking part in this study
  • Condition: Ulcerative Colitis
  • Intervention: Drug: Placebo IV Drug: Placebo SC Drug: Ustekinumab IV Drug: Ustekinumab SC
  • Clinic: GI Research Institute Suite 770-1190 Hornby Street, Vancouver, British Columbia, Canada

Summary

The purpose of this study is to evaluate the efficacy and safety of ustekinumab as intravenous (IV: into the vein) infusion in induction study in participants with moderately to severely active Ulcerative Colitis (UC) and as subcutaneous (SC) administration in maintenance study in participants with moderately to severely active Ulcerative Colitis (UC) who have demonstrated a clinical response to Induction treatment with IV ustekinumab.

Researchers

Brian bressler headshot for dt trial listings
Gastroenterologist

Full Trial Details